Pfizer (PFE)

Short-Term Debt

$2.70B

Quarterly · Period ending: · USD

PFE logo

PFE Short-Term Debt

Latest reported$2.70B
PFE Quarterly Short-Term Debt ($185.90M → $2.70B)
High-resolution chart · PNG

PFE short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
4,638,000,000
3,963,000,000
4,289,000,000
5,934,000,000
5,544,000,000
3,717,000,000
5,299,000,000
5,486,000,000
4,938,000,000
4,296,000,000
2,729,000,000
3,350,000,000
2,583,000,000
2,515,000,000
2,251,000,000
2,851,000,000
2,978,000,000
2,582,000,000
2,235,000,000
3,157,000,000
2,545,000,000
2,339,000,000
2,035,500,000
3,046,400,000
3,059,500,000
3,115,100,000
2,220,000,000
1,796,800,000
1,836,200,000
1,517,800,000
1,178,800,000
2,220,100,000
2,160,600,000
1,840,100,000
1,252,300,000
1,272,500,000
1,055,600,000
1,292,100,000
1,691,100,000
1,668,100,000
1,558,400,000
1,261,400,000
1,499,300,000
1,258,300,000
1,089,000,000
990,200,000
1,526,300,000
967,700,000
714,900,000
271,300,000
185,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.